Why PureLift Is More Than a Depuffing Tool

About the Authors

Bertica M. Rubio, M.D.

Bertica M. Rubio, M.D.

Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School

Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.

With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.

Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.

Andrew Conrad Barile, PT, DPT

Andrew Conrad Barile, PT, DPT

Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)

Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.

Daniel Grinberg, MD, FACS

Daniel Grinberg, MD, FACS

Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine

Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.

Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.

Prof. Dr. med. Ivo Buschmann

Prof. Dr. med. Ivo Buschmann

Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin

Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.

Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.

Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.

PureLift is often discovered through the depuffing story — the morning-puffiness fix, the pre-event refresh, the post-flight recovery look. Those are real and useful entry points. But the device's deeper architecture supports a broader set of outcomes that the depuffing framing alone doesn't quite capture.

The short version

  • PureLift's randomized PDM cycling supports depuffing, but also muscle activation, cumulative tone-building, and complexion brightness.
  • The deeper case for the device is the layered, multi-outcome effect across consistent use.
  • Depuffing is the most-immediate visible result; the longer-term sculpting and tone improvement is built on the same architecture.
  • Users who treat PureLift as a "depuffing tool" capture part of the value; users who use it consistently across weeks capture more.

The full outcome set

Depuffing (immediate). Each session produces visible fluid movement and reduces the puffy-face appearance.

Brighter complexion (immediate). The circulation support contributes to the brighter, more luminous look that holds for hours after.

More defined contours (immediate). The muscle activation lifts contours slightly, producing visible after-session definition.

Cumulative muscle tone (across weeks). Consistent sessions build resting muscle tone that holds contours higher even on off days.

Cumulative skin-quality improvement (across weeks). The supported circulation contributes to longer-term complexion benefits.

Stress-supportive routine. The act of doing a focused 10-minute self-care session has its own value.

What the architecture supports

The randomized PDM across 361 frequencies in the 1.37-1.73 kHz range was engineered for sustained muscle activation across the full session without the rapid neuromuscular adaptation that constant-frequency stimulation produces. This is the architecture for cumulative tone-building, not just acute depuffing.

The Triple-Wave™ delivery (PWM + AM + FM) combines three modulation strategies to keep the activation effective across the session.

The combination is purpose-built for the layered outcome set rather than for any single use case.

What the published evidence supports

Multiple outcome dimensions from the facial NMES literature:

  • Muscle thickness gains (Kavanagh 2012)
  • Cheek volume, jawline angle, submental volume, skin elasticity improvements (Omatsu 2024)
  • Blood flow improvements (Omatsu 2024)
  • Self-reported skin quality improvements (Kavanagh 2012)

All from the same kind of cycled facial NMES architecture PureLift uses.

The "depuffing tool" framing

It's an accurate framing for the immediate session-to-session effect. But it understates what the device does across consistent use. Users who use PureLift only for occasional depuffing get the immediate value. Users who use it 3-5 times per week for several months get the cumulative value too.

The honest framing

PureLift is a cosmetic-supportive device with a layered outcome profile. It is not a medical treatment. The cumulative effects depend on consistency; the immediate effects don't. Both are real; both are valuable.

The bottom line

Depuffing is the entry point; cumulative tone-building is the longer-term reward. PureLift's architecture supports both, in the same sessions. Treating it as more than a depuffing tool — using it consistently across weeks — unlocks the full outcome set.

For the cumulative-tone framing, see Why Lymphatic Drainage Is the Secret to a More Sculpted Face.

References: Kavanagh S et al. (2012), J Cosmet Dermatol 11(4):261-266, PMID 23174048. Omatsu J et al. (2024), J Cosmet Dermatol 23(10):3222-3233, PMID 38992992.

Back to blog